Legend Biotech Corporation
LEGN
$35.64
-$0.27-0.75%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -68.78% | 118.15% | -101.46% | 90.86% | 46.66% |
| Total Depreciation and Amortization | -9.14% | 34.57% | 10.40% | 8.03% | 31.39% |
| Total Amortization of Deferred Charges | -- | -54.63% | -37.07% | 212.82% | -- |
| Total Other Non-Cash Items | 368.04% | -164.91% | 5,009.75% | -100.15% | -5,251.42% |
| Change in Net Operating Assets | -178.25% | -682.99% | -579.19% | 142.57% | 395.39% |
| Cash from Operations | -768.60% | 14.18% | -24.61% | 98.31% | 111.15% |
| Capital Expenditure | 67.94% | 45.27% | 61.60% | 43.87% | -46.12% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 166.33% | -120.75% | 262.57% | -499.10% | -2,025.16% |
| Cash from Investing | 164.78% | -121.56% | 257.40% | -471.67% | -2,570.98% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -2.51% | -407.89% | 32.36% | 23.88% | 6.88% |
| Issuance of Common Stock | -9.13% | -2.90% | 101.68% | -99.73% | 329.46% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -19.74% | -136.00% | 341.73% | -99.88% | 287.16% |
| Foreign Exchange rate Adjustments | 508.16% | -256.46% | 166.84% | -99.62% | 85.43% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 140.76% | -154.90% | 195.66% | -221.49% | -201.75% |